In BlephEx, LLC v. Myco Industries, Inc., Nos. 21-1149, 21-1365 (Fed. Cir. Feb. 3, 2022), the Federal Circuit affirmed the Eastern District of Michigan's preliminary injunction enjoining Myco from selling its product AB Max, .
A weekly summary of the precedential patent-related opinions issued by the Court of Appeals for the Federal Circuit and the opinions designated precedential or informative by the Patent Trial and Appeal Board.
In BlephEx, LLC v. Myco Industries, Inc., Nos. 21-1149, 21-1365, the Federal Circuit affirmed the Eastern District of Michigan’s preliminary injunction enjoining Myco from selling its product AB Max, used for treating blepharitis, an inflammation of the eyelids.
A weekly summary of the precedential patent-related opinions issued by the Court of Appeals for the Federal Circuit and the opinions designated precedential or informative by the Patent.
A weekly summary of the precedential patent-related opinions issued by the Court of Appeals for the Federal Circuit and the opinions designated precedential or informative by the Patent Trial and Appeal Board.